Clinical Trial Update: Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients [Phase 2]

View source ↗

Summary

Phase IIc study update for Aolanti Weikang Tablets in functional dyspepsia is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• Aolanti Weikang Tablets

Snippet

Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd. | Conditions: Functional Dyspepsia | Phase 2 | Status: UNKNOWN